Sign in
Independent · Fearless · Informed

The Daily Ledger

Est. 1897 — Trusted by readers worldwide
← The Ledger
Health & Science

The Brain Implant That Let a Paralysed Man Type with His Thoughts

James Merritt was twenty-nine years old and three months into a new job as a structural engineer when a cycling accident severed his spinal cord at the C4 vertebra, leaving him paralysed from the neck down and unable to speak above a whisper. For two years he communicated through an eye-tracking system that let him select letters on a screen at roughly eight words per minute — functional, but agonisingly slow for a man accustomed to filling whiteboards with equations. Today, thanks to a surgically implanted brain-computer interface, Merritt types at sixty-two words per minute — approximately 90% of his pre-injury speed — using nothing but his thoughts.

The device, developed by NeuroLink Systems, a Stanford University spinout, consists of a 256-electrode array implanted on the surface of the motor cortex, the region of the brain that controls voluntary movement. When Merritt imagines moving his hand to type, the array captures the resulting neural signals and transmits them wirelessly to an external processor, which decodes the intended keystrokes in real time. The system requires no physical movement whatsoever — only the intention to move.

"The first time I wrote a full sentence without looking at a screen full of letters, I cried," Merritt said in a video interview conducted entirely through the device. "It felt like getting a piece of myself back. Not all of it. But a piece I thought was gone forever."

The results, published last month in the journal Neural Engineering, represent a significant leap beyond previous brain-computer interfaces, which typically achieved speeds of fifteen to twenty words per minute and required extensive daily recalibration. NeuroLink's system, by contrast, maintains accuracy above 95% across sessions spanning weeks, a durability that Dr. Sarah Kimura, the neurosurgeon who led the implant team, attributes to advances in both electrode materials and the machine-learning algorithms that decode the neural signals.

"Previous generations of electrodes degraded within months as the body's immune response encapsulated them in scar tissue," Dr. Kimura explained. "Our array uses a biocompatible polymer coating that dramatically slows that process. Combined with adaptive algorithms that continuously recalibrate to the changing signal environment, we are seeing stable performance at twelve months — which was our primary endpoint — and we have every reason to believe it will extend well beyond that."

The device received FDA clearance through the breakthrough-device pathway following an eleven-patient clinical trial in which all participants achieved communication speeds at least three times faster than their pre-implant assistive technology. The trial's safety profile was favourable — two patients experienced minor surgical-site infections that resolved with antibiotics, and no serious adverse events were reported — though the long-term risks of a permanently implanted brain electrode remain an area of active study.

The cost, however, is formidable. The device, surgery, and first year of clinical support carry a price tag of approximately $180,000, a figure that places it out of reach for the vast majority of the estimated 5.4 million Americans living with paralysis. Insurance coverage is uncertain; Medicare has not yet issued a determination, and private insurers are taking a wait-and-see approach. "The technology is extraordinary," said disability-rights advocate Martin Okafor. "But if only the wealthy can access it, we have created a world in which the ability to communicate depends on the ability to pay. That should trouble everyone."

Beyond access, the technology raises philosophical questions that its creators acknowledge but cannot resolve. If a brain-computer interface can restore lost function, can it also enhance function beyond the baseline — allowing a healthy person to type or control devices faster than their body would permit? And if so, where is the line between therapy and augmentation? "We built this for people who have lost something," Dr. Kimura said. "But the technology does not know the difference between restoring a capability and creating a new one. Society will have to draw that line. We cannot draw it for them."

For Merritt, the philosophical questions are secondary to the practical reality. He has returned to part-time consulting work, manages his own correspondence, and recently wrote a twelve-page letter to his niece explaining, in detail, the engineering principles behind her favourite roller coaster. "People ask me what it feels like," he said. "It feels like thinking. That is literally what it is. I think the words, and the words appear. After two years of spelling things out one letter at a time with my eyes, that is not a technological miracle. It is a human one."

Listen as a Podcast

Pick two voices and we'll generate an AI podcast — two hosts discussing this article in a natural, conversational style. Powered by Workers AI.

View transcript